Unknown PHASE2 INTERVENTIONAL 3-arm NCT03232554

Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia (BXYMIDA)

Clinical Observation of The Gynecological Iron-Deficiency Anemia Treated With Buxue Yimu Pills

Sponsor: Peking Union Medical College Hospital

Interventions Buxue Yimu Pills Buxue Yimu Pills &Ferrous Sulfate Ferrous Sulfate

Updated 8 times since 2017 Last updated: Feb 10, 2018 Started: Jun 1, 2017 Primary completion: Dec 31, 2018 Completion: Feb 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Iron-Deficiency Anemia and is currently ongoing. Peking Union Medical College Hospital leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Mar 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Aug 2018 — Mar 2020 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Jul 2018 — Aug 2018 [monthly]

Recruiting PHASE2
Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE2
Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China